Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Cerilliant
Federal Trade Commission
US Department of Justice
Fuji
Healthtrust
Fish and Richardson
Citi
Deloitte

Generated: June 22, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,572,912

« Back to Dashboard

Summary for Patent: 4,572,912
Title: Thiazolidine derivatives, their preparation and compositions containing them
Abstract:The compounds of formula (I): ##STR1## [in which: R.sup.1 and R.sup.2 are the same or different and each represents hydrogen or C.sub.1 -C.sub.5 alkyl; R.sup.3 represents hydrogen, an acyl group, a (C.sub.1 -C.sub.6 alkoxy)carbonyl group or an aralkyloxycarbonyl group; R.sup.4 and R.sup.5 are the same or different and each represents hydrogen, C.sub.1 -C.sub.5 alkyl or C.sub.1 -C.sub.5 alkoxy, or R.sup.4 and R.sup.5 together represent a C.sub.1 14 C.sub.4 alkylenedioxy group; n is 1, 2 or 3; W represents the --CH.sub.2 --, >CO or >CH--OR.sup.6 group (in which R.sup.6 represents any one of the atoms or groups defined for R.sup.3 and may be the same as or different from R.sup.3); and Y and Z are the same or different and each represents oxygen or imino] and pharmaceutically acceptable salts thereof have various valuable therapeutic effects on the blood system and may be prepared by a process which includes reacting a corresponding halopropionic acid derivative with thiourea.
Inventor(s): Yoshioka; Takao (Hiromachi, JP), Kitazawa; Eiici (Hiromachi, JP), Kurumada; Tomoyuki (Hiromachi, JP), Yamazaki; Mitsuo (Hiromachi, JP), Hasegawa; Kazou (Hiromachi, JP)
Assignee: Sankyo Company Limited (Tokyo, JP)
Application Number:06/644,996
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 4,572,912
Patent Claim Types:
see list of patent claims
Compound; Use; Composition;

Drugs Protected by US Patent 4,572,912

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 4,572,912

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan58-158375Aug 30, 1983

International Family Members for US Patent 4,572,912

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 33838 ➤ Try a Free Trial
Australia 3255984 ➤ Try a Free Trial
Australia 570067 ➤ Try a Free Trial
Canada 1263395 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Chinese Patent Office
Farmers Insurance
Teva
Fuji
Medtronic
Deloitte
McKinsey
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.